# Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

> **NCT04213326** · — · COMPLETED · sponsor: **Exact Sciences Corporation** · enrollment: 6400 (actual)

## Conditions studied

- Early Cancer Detection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04213326
- **Lead sponsor:** Exact Sciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2021-01-29
- **Final completion:** 2021-01-29
- **Target enrollment:** 6400 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04213326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04213326, "Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04213326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*